INDRAMEDCO — Indraprastha Medical Cashflow Statement
0.000.00%
- IN₹41.19bn
- IN₹38.21bn
- IN₹13.56bn
- 79
- 22
- 87
- 71
Annual cashflow statement for Indraprastha Medical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 42.9 | 791 | 1,172 | 1,661 | 2,163 |
Depreciation | |||||
Non-Cash Items | 8.48 | 32.6 | -87 | -147 | -191 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -106 | -460 | -32.8 | 86.2 | -848 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 279 | 713 | 1,445 | 2,002 | 1,568 |
Capital Expenditures | -210 | -295 | -446 | -694 | -363 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 8.01 | -216 | -633 | -890 | -747 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -202 | -511 | -1,079 | -1,584 | -1,110 |
Financing Cash Flow Items | -8.09 | -6 | -3.7 | -10.5 | -30.2 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -31.5 | -33.7 | -260 | -324 | -459 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 45.9 | 168 | 105 | 93.4 | -1.2 |